Revolutionary drug for schizophrenia wins US approval
Elie Dolgin • September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
Read at Nature.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.